Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1988-08-01
1990-10-02
Stone, Jacqueline
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514802, 514970, 514 8, 530382, A61K 3702, A61K 3516, C07K 1506
Patent
active
049607570
ABSTRACT:
A pasteurized human firbinogen which can be used therapeutically, and a process for its preparation are described.
REFERENCES:
patent: 4297344 (1981-10-01), Schwinn et al.
patent: 4327086 (1982-04-01), Fukushima et al.
patent: 4405603 (1983-09-01), Schwinn et al.
patent: 4440679 (1984-04-01), Fernandex
Marguerie, "The Binding of Calcium to Fibrinogen", Biochimica et Biophysica Acta 494(1977) 172-181.
Altman et al., eds., Biology Data Book, pp. 1751-1753 2nd ed. vol. III.
Lawrie et al., "The Presence of a Catt Bridge . . . " Biochim et Biophys Acta 577 (1979) pp. 415-423.
Chem. Abstracts, vol. 86:91761p Lim, Jong Jir.
Fuhge Peter
Heimburger Norbert
Kumpe Gerhardt
Preis Hans M.
Wormsbacher Wilfried
Behringwerke Aktiengesellschaft
Stone Jacqueline
LandOfFree
Pasteurized human fibrinogen (HF), a process for its preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pasteurized human fibrinogen (HF), a process for its preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pasteurized human fibrinogen (HF), a process for its preparation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-292519